Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | UT8437BA | OT / RA |
administered expired FLUZONE NP from last year with no reported adverse event; Initial information received on 14-Oct-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to this case US-SA-2025SA308068. This case involves a 70 years old female patient who administered an expired Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone] from last year with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Oct-2025, the patient received 0.5 ml dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine, Suspension for injection, lot UT8437BA, strength: standard, expiry date:30-Jun-2025,Frequency :once, via intramuscular route in the right deltoid for Influenza, from last year with no reported adverse event (expired product administered) (latency: same day). Reportedly,Caller states that she needs assistance with 2 things. She needs to order some high dose vaccines from Vaccine Shoppe; she states that she tried to go online, but she couldn't log in. She also needs to report that 2doses of FLUZONE NP from last year were administered to 2 patients. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA308068:2nd Patient